{"id":50383,"date":"2022-11-02T15:02:27","date_gmt":"2022-11-02T14:02:27","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/"},"modified":"2022-11-02T15:02:27","modified_gmt":"2022-11-02T14:02:27","slug":"pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/","title":{"rendered":"Pharma R&amp;D Outsourcing Global Market Report 2022: Paradigm Shift Towards Virtual Clinical Trials Reshaping Sector &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5661145\/pharma-randd-outsourcing-market-global-outlook?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=q5695k&amp;utm_campaign=1770476+-+Pharma+R%26D+Outsourcing+Global+Market+Report+2022%3A+Paradigm+Shift+Towards+Virtual+Clinical+Trials+Reshaping+Sector&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Pharma R&amp;D Outsourcing Market &#8211; Global Outlook &amp; Forecast 2022-2027&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221102005672\/en\/1622610\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221102005672\/en\/1622610\/21\/logo.jpg\"><\/a><\/p>\n<p>\nIn a world of exponentially growing information, increasingly sophisticated technology, and an unstable economic environment, pharmaceutical corporations are increasingly outsourcing research efforts to academia and private contract research organizations (CROs).\n<\/p>\n<p>\nThe pharmaceutical R&amp;D outsourcing market is expected to grow as pharmaceutical and biotechnology companies spend more on outsourced services. Outsourced R&amp;D activities span basic research through late-stage development, including genetic engineering, target identification, target validation, assay creation, hit discovery and lead optimization (hit candidates-as-a-service), safety and efficacy assessments in animal studies, and human clinical trials.\n<\/p>\n<p>\n<strong>MARKET DYNAMICS<\/strong>\n<\/p>\n<p>\n<strong>Paradigm Shift Towards Virtual Clinical Trials<\/strong>\n<\/p>\n<ul>\n<li>\nVirtual clinical trials or decentralized clinical trials can bring significant digital changes to clinical research methods and enhance the patient-centric ecosystem. These solutions include countless benefits such as technology, advanced applications, electronic devices, online social engagement platforms, artificial intelligence (AI), robotic process automation, and machine learning (ML).\n<\/li>\n<li>\nPatient recruitment is the most prominent cause of clinical delay, followed by significant patient absenteeism. Approximately 30% of phase 3 study discontinuances are said to be due to difficulty recruiting patients. These delays can cost pharmaceutical companies\/sponsors up to USD 8 million daily. However, a complete digital or cross model of patient enrolment is employed in decentralized clinical trials. This helps reach the recruitment target easily and rapidly, making the entire process easy, and engaging.\n<\/li>\n<\/ul>\n<p>\n<strong>The Emergence of Artificial intelligence (AI) in Drug Discovery &amp; Development<\/strong>\n<\/p>\n<ul>\n<li>\nArtificial intelligence (AI) is used in numerous areas across the world. In healthcare, especially in the pharmaceutical industry, AI is making a notable change as it has varied uses in drug discovery &amp; development, clinical trials, and pharmaceutical productivity. The life cycle of a new drug from a lab to a store is a chain of many complex events that take time and development. Such difficult circumstances can be minimized with the help of AI, and the target can be achieved in a short time.\n<\/li>\n<li>\nMany pharmaceutical companies implement innovative technologies such as AI and machine learning to achieve high-quality results in a short amount of time. In pharmaceutical product development, AI can manage the drug designing, decision making, and therapy determination for patients with personalized medicines; the generated clinical data can be stored for future drug development.\n<\/li>\n<li>\nGlobal key players from the pharma and biotech industry, such as Eli Lilly Amgen, Merck, LEO, AstraZeneca, Bayer, Novartis, J&amp;J, and BASF, are now a part of machine learning for pharmaceutical discovery.\n<\/li>\n<\/ul>\n<p>\n<strong>Increasing Collaboration and partnership among CROs and Stakeholders of the Pharmaceutical Ecosystem<\/strong>\n<\/p>\n<ul>\n<li>\nNew models are emerging, and the first innovation comes from the Clinical Research Organization (CRO). CROs establish early chemical \/ biological entry points for the disease, approach potential interested companies, and collaborate on integrated drug discovery projects that they have identified. Strategic partnerships have long been an essential feature of the pharmaceutical industry. Numerous in-licenses, out-licenses, joint research, and joint development agreements exist between biopharmaceutical companies and academic research institutes.\n<\/li>\n<li>\nIn recent years, several significant outsourcing partnerships were done, such as the UK-based AstraZeneca partnering with academic organizations, the Cambridge University, focusing on drug development. It partnered with the University of Texas MD Anderson Cancer Center in the United States to develop immunotherapy.\n<\/li>\n<\/ul>\n<p>\n<strong>SEGMENTATION ANALYSIS<\/strong>\n<\/p>\n<p>\n<strong>Segmentation by Product Type<\/strong>\n<\/p>\n<ul>\n<li>\nSmall Molecules\n<\/li>\n<li>\nBiologics\n<\/li>\n<\/ul>\n<p>\n<strong>Segmentation by Stage of Development<\/strong>\n<\/p>\n<ul>\n<li>\nClinical\n<\/li>\n<li>\nNon-Clinical\n<\/li>\n<\/ul>\n<p>\n<strong>Segmentation by Company Size<\/strong>\n<\/p>\n<ul>\n<li>\nSmall &amp; Mid-Sized Companies\n<\/li>\n<li>\nLarge Companies\n<\/li>\n<\/ul>\n<p>\n<strong>Segmentation by Therapy Area<\/strong>\n<\/p>\n<ul>\n<li>\nOncology\n<\/li>\n<li>\nCardiovascular Diseases\n<\/li>\n<li>\nInfectious Diseases\n<\/li>\n<li>\nMusculoskeletal Disorders\n<\/li>\n<li>\nCentral Nervous System Disorders\n<\/li>\n<li>\nGastrointestinal Disorders\n<\/li>\n<li>\nOther Therapy Areas.\n<\/li>\n<\/ul>\n<p>\n<strong>Segmentation by Geography<\/strong>\n<\/p>\n<ul>\n<li>\nNorth America\n<\/li>\n<li>\nUS\n<\/li>\n<li>\nCanada\n<\/li>\n<li>\nEurope\n<\/li>\n<li>\nGermany\n<\/li>\n<li>\nUK\n<\/li>\n<li>\nFrance\n<\/li>\n<li>\nItaly\n<\/li>\n<li>\nSpain\n<\/li>\n<li>\nAPAC\n<\/li>\n<li>\nChina\n<\/li>\n<li>\nJapan\n<\/li>\n<li>\nIndia\n<\/li>\n<li>\nAustralia\n<\/li>\n<li>\nSouth Korea\n<\/li>\n<li>\nLatin America\n<\/li>\n<li>\nBrazil\n<\/li>\n<li>\nMexico\n<\/li>\n<li>\nArgentina\n<\/li>\n<li>\nMiddle East &amp; Africa\n<\/li>\n<li>\nSouth Africa\n<\/li>\n<li>\nSaudi Arabia\n<\/li>\n<li>\nTurkey\n<\/li>\n<li>\nUAE\n<\/li>\n<\/ul>\n<p>\n<strong>Key Vendors<\/strong>\n<\/p>\n<ul>\n<li>\nCharles River Laboratories\n<\/li>\n<li>\nICON\n<\/li>\n<li>\nIQVIA\n<\/li>\n<li>\nLabcorp Drug Development\n<\/li>\n<li>\nMedpace\n<\/li>\n<li>\nParexel International Corporation\n<\/li>\n<li>\nSyneos Health\n<\/li>\n<li>\nThermo Fisher Scientific\n<\/li>\n<li>\nWuxi AppTec\n<\/li>\n<li>\nLonza\n<\/li>\n<li>\nBoehringer Ingelheim\n<\/li>\n<li>\nSamsung Biologics\n<\/li>\n<\/ul>\n<p>\n<strong>Other Prominent Vendors<\/strong>\n<\/p>\n<ul>\n<li>\nAbbVie\n<\/li>\n<li>\nAdvanced Clinical\n<\/li>\n<li>\nBioAnalytix\n<\/li>\n<li>\nAsymchem\n<\/li>\n<li>\nAlcami\n<\/li>\n<li>\nBavarian Nordic\n<\/li>\n<li>\nCatalent\n<\/li>\n<li>\nCuria Global\n<\/li>\n<li>\nChemPartner\n<\/li>\n<li>\nCMED\n<\/li>\n<li>\nCriterium\n<\/li>\n<li>\nCromos Pharma\n<\/li>\n<li>\nEvotec\n<\/li>\n<li>\nJubilant HollisterStier\n<\/li>\n<li>\nKBI Biopharma\n<\/li>\n<li>\nKCR S.A.\n<\/li>\n<li>\nKemwell Biopharma\n<\/li>\n<li>\nMesned Pharma Consult Center\n<\/li>\n<li>\nMidas Pharma\n<\/li>\n<li>\nMedelis\n<\/li>\n<li>\nMerck KGaA\n<\/li>\n<li>\nOCT Clinical\n<\/li>\n<li>\nPharmaceutics International\n<\/li>\n<li>\nProTrials Research\n<\/li>\n<li>\nPROMETRIKA\n<\/li>\n<li>\nQPS\n<\/li>\n<li>\nSingota Solutions\n<\/li>\n<li>\nSofpromed\n<\/li>\n<li>\nSanofi\n<\/li>\n<li>\nTaros chemicals\n<\/li>\n<li>\nVeristat\n<\/li>\n<li>\nWorldwide Clinical Trials\n<\/li>\n<li>\nWuXi Biologics\n<\/li>\n<li>\nWacker Biotech B.V\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Research Methodology<\/strong>\n<\/p>\n<p>\n<strong>2 Research Objectives<\/strong>\n<\/p>\n<p>\n<strong>3 Research Process<\/strong>\n<\/p>\n<p>\n<strong>4 Scope &amp; Coverage<\/strong>\n<\/p>\n<p>\n<strong>5 Report Assumptions &amp; Caveats<\/strong>\n<\/p>\n<p>\n<strong>6 Market at a Glance<\/strong>\n<\/p>\n<p>\n<strong>7 Introduction<\/strong>\n<\/p>\n<p>\n<strong>8 Premium Insights<\/strong>\n<\/p>\n<p>\n<strong>9 Market Opportunities &amp; Trends<\/strong>\n<\/p>\n<p>\n<strong>10 Market Growth Enablers<\/strong>\n<\/p>\n<p>\n<strong>11 Market Restraints<\/strong>\n<\/p>\n<p>\n<strong>12 Market Landscape<\/strong>\n<\/p>\n<p>\n<strong>13 Stage of Development<\/strong>\n<\/p>\n<p>\n<strong>14 Product<\/strong>\n<\/p>\n<p>\n<strong>15 Company Size<\/strong>\n<\/p>\n<p>\n<strong>16 Therapy Area<\/strong>\n<\/p>\n<p>\n<strong>17 Geography<\/strong>\n<\/p>\n<p>\n<strong>18 North America<\/strong>\n<\/p>\n<p>\n<strong>19 Europe<\/strong>\n<\/p>\n<p>\n<strong>20 APAC<\/strong>\n<\/p>\n<p>\n<strong>21 Latin America<\/strong>\n<\/p>\n<p>\n<strong>22 Middle East &amp; Africa<\/strong>\n<\/p>\n<p>\n<strong>23 Competitive Landscape<\/strong>\n<\/p>\n<p>\n<strong>24 Key Company Profiles<\/strong>\n<\/p>\n<p>\n<strong>25 Other Prominent Vendors<\/strong>\n<\/p>\n<p>\n<strong>26 Report Summary<\/strong>\n<\/p>\n<p>\n<strong>27 Quantitative Summary<\/strong>\n<\/p>\n<p>\n<strong>28 Appendix<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5661145\/pharma-randd-outsourcing-market-global-outlook?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=q5695k&amp;utm_campaign=1770476+-+Pharma+R%26D+Outsourcing+Global+Market+Report+2022%3A+Paradigm+Shift+Towards+Virtual+Clinical+Trials+Reshaping+Sector&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/1n4on2<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x70;&#x72;&#x65;&#x73;&#x73;&#x40;&#x72;&#x65;&#x73;&#x65;&#x61;&#x72;&#x63;&#x68;&#x61;&#x6e;&#x64;&#x6d;&#x61;&#x72;&#x6b;&#x65;&#x74;&#x73;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#x65;&#x73;&#x73;&#x40;&#x72;&#x65;&#x73;&#x65;&#x61;&#x72;&#x63;&#x68;&#x61;&#x6e;&#x64;&#x6d;&#x61;&#x72;&#x6b;&#x65;&#116;&#115;&#46;&#99;&#111;&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Pharma R&amp;D Outsourcing Market &#8211; Global Outlook &amp; Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. In a world of exponentially growing information, increasingly sophisticated technology, and an unstable economic environment, pharmaceutical corporations are increasingly outsourcing research efforts to academia and private contract research organizations (CROs). The pharmaceutical R&amp;D outsourcing market is &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50383","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharma R&amp;D Outsourcing Global Market Report 2022: Paradigm Shift Towards Virtual Clinical Trials Reshaping Sector - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma R&amp;D Outsourcing Global Market Report 2022: Paradigm Shift Towards Virtual Clinical Trials Reshaping Sector - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Pharma R&amp;D Outsourcing Market &#8211; Global Outlook &amp; Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. In a world of exponentially growing information, increasingly sophisticated technology, and an unstable economic environment, pharmaceutical corporations are increasingly outsourcing research efforts to academia and private contract research organizations (CROs). The pharmaceutical R&amp;D outsourcing market is ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-02T14:02:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221102005672\/en\/1622610\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Pharma R&amp;D Outsourcing Global Market Report 2022: Paradigm Shift Towards Virtual Clinical Trials Reshaping Sector &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-11-02T14:02:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\\\/\"},\"wordCount\":856,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221102005672\\\/en\\\/1622610\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\\\/\",\"name\":\"Pharma R&amp;D Outsourcing Global Market Report 2022: Paradigm Shift Towards Virtual Clinical Trials Reshaping Sector - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221102005672\\\/en\\\/1622610\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-11-02T14:02:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221102005672\\\/en\\\/1622610\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221102005672\\\/en\\\/1622610\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma R&amp;D Outsourcing Global Market Report 2022: Paradigm Shift Towards Virtual Clinical Trials Reshaping Sector &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharma R&amp;D Outsourcing Global Market Report 2022: Paradigm Shift Towards Virtual Clinical Trials Reshaping Sector - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Pharma R&amp;D Outsourcing Global Market Report 2022: Paradigm Shift Towards Virtual Clinical Trials Reshaping Sector - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Pharma R&amp;D Outsourcing Market &#8211; Global Outlook &amp; Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. In a world of exponentially growing information, increasingly sophisticated technology, and an unstable economic environment, pharmaceutical corporations are increasingly outsourcing research efforts to academia and private contract research organizations (CROs). The pharmaceutical R&amp;D outsourcing market is ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-02T14:02:27+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221102005672\/en\/1622610\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Pharma R&amp;D Outsourcing Global Market Report 2022: Paradigm Shift Towards Virtual Clinical Trials Reshaping Sector &#8211; ResearchAndMarkets.com","datePublished":"2022-11-02T14:02:27+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/"},"wordCount":856,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221102005672\/en\/1622610\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/","name":"Pharma R&amp;D Outsourcing Global Market Report 2022: Paradigm Shift Towards Virtual Clinical Trials Reshaping Sector - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221102005672\/en\/1622610\/21\/logo.jpg","datePublished":"2022-11-02T14:02:27+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221102005672\/en\/1622610\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221102005672\/en\/1622610\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Pharma R&amp;D Outsourcing Global Market Report 2022: Paradigm Shift Towards Virtual Clinical Trials Reshaping Sector &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50383","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50383"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50383\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50383"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}